These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15741268)

  • 1. Sex hormone suppression reduces resting energy expenditure and {beta}-adrenergic support of resting energy expenditure.
    Day DS; Gozansky WS; Van Pelt RE; Schwartz RS; Kohrt WM
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3312-7. PubMed ID: 15741268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effects of a progestational contraceptive drug on food intake, resting energy expenditure, and body weight in young women.
    Pelkman CL; Chow M; Heinbach RA; Rolls BJ
    Am J Clin Nutr; 2001 Jan; 73(1):19-26. PubMed ID: 11124744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of energy expenditure by estradiol in premenopausal women.
    Melanson EL; Gavin KM; Shea KL; Wolfe P; Wierman ME; Schwartz RS; Kohrt WM
    J Appl Physiol (1985); 2015 Nov; 119(9):975-81. PubMed ID: 26338457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition.
    Kettel LM; Roseff SJ; Chiu TC; Bangah ML; Vale W; Rivier J; Burger HG; Yen SS
    J Clin Endocrinol Metab; 1991 Sep; 73(3):644-9. PubMed ID: 1908486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human.
    Hall JE; Bhatta N; Adams JM; Rivier JE; Vale WW; Crowley WF
    J Clin Endocrinol Metab; 1991 May; 72(5):993-1000. PubMed ID: 1902489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No effect of menstrual cycle phase on glucose kinetics and fuel oxidation during moderate-intensity exercise.
    Horton TJ; Miller EK; Glueck D; Tench K
    Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E752-62. PubMed ID: 11882494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women.
    Reame NE; Kelche RP; Beitins IZ; Yu MY; Zawacki CM; Padmanabhan V
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1512-8. PubMed ID: 8636360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
    Molskness TA; Woodruff TK; Hess DL; Dahl KD; Stouffer RL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary and metabolic differences in pre- versus postmenopausal women taking or not taking hormone replacement therapy.
    Reimer RA; Debert CT; House JL; Poulin MJ
    Physiol Behav; 2005 Feb; 84(2):303-12. PubMed ID: 15708782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of luteal phase deficiency and anovulation in recreational women runners: blunted elevation in follicle-stimulating hormone observed during luteal-follicular transition.
    De Souza MJ; Miller BE; Loucks AB; Luciano AA; Pescatello LS; Campbell CG; Lasley BL
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4220-32. PubMed ID: 9851755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the decrease in the hypophysiotropic signal frequency normally observed during the luteal phase important for menstrual cyclicity in the primate?
    Lam NY; Ferin M
    Endocrinology; 1987 May; 120(5):2044-9. PubMed ID: 3552630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resting sympathetic activity is associated with the sympathetically mediated component of energy expenditure following a meal.
    Limberg JK; Malterer KR; Matzek LJ; Levine JA; Charkoudian N; Miles JM; Joyner MJ; Curry TB
    Physiol Rep; 2017 Aug; 5(16):. PubMed ID: 28867675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation of symptoms during the menstrual cycle in female patients with gastroparesis.
    Verrengia M; Sachdeva P; Gaughan J; Fisher RS; Parkman HP
    Neurogastroenterol Motil; 2011 Jul; 23(7):625-e254. PubMed ID: 21332597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin enhances the luteinizing hormone and follicle-stimulating hormone responses to gonadotropin-releasing hormone in the follicular, but not in the luteal, menstrual phase.
    Cagnacci A; Paoletti AM; Soldani R; Orrù M; Maschio E; Melis GB
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1095-9. PubMed ID: 7714075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicted versus measured resting energy expenditure in patients requiring home parenteral nutrition.
    Ławiński M; Singer P; Gradowski Ł; Gradowska A; Bzikowska A; Majewska K
    Nutrition; 2015; 31(11-12):1328-32. PubMed ID: 26278135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal oxygen consumption during different phases of menstrual cycle.
    Das TK; Jana H
    Indian J Med Res; 1991 Feb; 94():16-9. PubMed ID: 2071178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early initiation of gonadotropin-releasing hormone antagonist treatment results in a more stable endocrine milieu during the mid- and late-follicular phases: a randomized controlled trial comparing gonadotropin-releasing hormone antagonist initiation on cycle day 2 or 6.
    Hamdine O; Broekmans FJ; Eijkemans MJ; Lambalk CB; Fauser BC; Laven JS; Macklon NS;
    Fertil Steril; 2013 Sep; 100(3):867-74. PubMed ID: 23809501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute sex hormone suppression reduces skeletal muscle sympathetic nerve activity.
    Day DS; Gozansky WS; Bell C; Kohrt WM
    Clin Auton Res; 2011 Oct; 21(5):339-45. PubMed ID: 21638047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable ovarian response to gonadotropin-releasing hormone antagonist-induced gonadotropin deprivation during different phases of the menstrual cycle.
    Fluker MR; Marshall LA; Monroe SE; Jaffe RB
    J Clin Endocrinol Metab; 1991 Apr; 72(4):912-9. PubMed ID: 2005218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.